Prof. Dr. Michael Klein will leave the Board of Directors of Xlife Sciences AG, at its AGM to be held on June 20, 2022 but will remain with the company as a member of the Advisory Board. He will hand over the chairmanship of the Advisory Board to Dr. Norbert Windhab. Christian Faber will leave the Board of Directors on June 20, 2022, and instead join the management team of Xlife Sciences, where he will take on additional management responsibilities in addition to his current role as the company's Legal and Compliance Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.3 CHF | 0.00% | +1.18% | -31.26% |
Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.26% | 214M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- XLS Stock
- News Xlife Sciences AG
- Xlife Sciences AG Announces Management Changes